Ultrasound Guided- Chemical Rectus Sheath Block for Chronic Pain After Abdominal Midline Incision in Cancer Surgeries

RecruitingNot applicableNCT07855380

View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The aim of this study is to evaluate peri-operative analgesia efficacy of ultrasound guided transversalis fascia plane block in cancer patients undergoing inguinal lymph node dissection

Study details

Official title: Evaluation of Ultrasound Guided- Chemical Rectus Sheath Block for Chronic Pain After Abdominal Midline Incision in Cancer Surgeries: A Prospective Randomized Controlled Study
Conditions: Chemical Rectus Sheath Block
Chronic Pain
Abdominal Midline Incision
Cancer Surgeries
Interventions: Drug: Saline 0.9%
Drug: Transversalis fascia plane block
Sponsor: National Cancer Institute, Egypt
Start date: 2026-05-01
Primary completion: 2026-12-01
Sex: All
Age range: from 18 Years to 65 Years
Results posted: No results posted in this snapshot
Countries: Egypt
Total sites listed: 1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)

Inclusion Criteria: * American Society of Anesthesiologists (ASA) class I and II. * Age ≥ 18 and ≤ 65 Years. * Cancer patients for inguinal lymph node dissection. * Body mass index (BMI): \> 20 kg/m2 and \< 40 kg/m2. Exclusion Criteria: * Patient refusal. * Local infection at the puncture site. * Coagulopathies with platelet count below 50,000 or an INR\>1.6. * Unstable cardiovascular disease. * History of psychiatric and cognitive disorders. * Patients allergic to medication used.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07855380